A Bright Opportunity for Growth

The time for embracing an innovative dry eye solution is here!

Dry eye disease (DED) is one of the most common eye conditions, reportedly affecting between 49 million and 130 million American adults - only half of which have been diagnosed. Given this, it should come as no surprise that 45% of ophthalmology and optometry patients today are suffering from DED.

However, despite all this, available treatments have only provided partial or temporary relief. Until now!

In this e-book we will discuss the magnitude of the effect of DED and present a real solution, by Lumenis.

OptiLIGHT’s light therapy for dry eye management, together with OptiPLUS’ innovative dual frequency RF technology, offers patients a quick, safe and effective treatment, while providing practitioners the opportunity to grow and elevate their practices!